Tech Company Financing Transactions

Mirum Pharmaceuticals Funding Round

Mirum Pharmaceuticals secured a $120 million Series A funding round on 11/8/2018. Backers included New Enterprise Associates, Deerfield Capital and Frazier Healthcare Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
In an effort to bring maralixibat to patients as quickly as possible, Mirum plans to initiate Phase 3 confirmatory studies in patients with ALGS and PFIC in 2019.

Company Information

Company Status
Mailing Address
950 Tower Ln. 1050
Foster City, CA 94404
Email Address
Mirum Pharmaceuticals Inc. (Nasdaq: MIRM) is a therapeutics company developing a novel approach for treating cholestatic liver diseases, with an immediate focus on rare pediatric conditions.
Mirum Pharmaceuticals LinkedIn Company Profile
Social Media
Mirum Pharmaceuticals Company Twitter Account
Company News
Mirum Pharmaceuticals News
Mirum Pharmaceuticals on Facebook
Mirum Pharmaceuticals on YouTube

Management Team

Email & Social
Michael Grey
  Michael Grey LinkedIn Profile  Michael Grey Twitter Account  Michael Grey News  Michael Grey on Facebook
Chief Executive Officer
Chris Peetz
  Chris Peetz LinkedIn Profile  Chris Peetz Twitter Account  Chris Peetz News  Chris Peetz on Facebook
Chief Financial Officer
Ian Clements
  Ian Clements LinkedIn Profile  Ian Clements Twitter Account  Ian Clements News  Ian Clements on Facebook
Chief Medical Officer
Ed Tucker
  Ed Tucker LinkedIn Profile  Ed Tucker Twitter Account  Ed Tucker News  Ed Tucker on Facebook
Chief Operating Officer
Peter Radovich
  Peter Radovich LinkedIn Profile  Peter Radovich Twitter Account  Peter Radovich News  Peter Radovich on Facebook
VP - Bus. Development
Lara Longpre
  Lara Longpre LinkedIn Profile  Lara Longpre Twitter Account  Lara Longpre News  Lara Longpre on Facebook



Browse more venture capital transactions:

Prev: 11/8/2018: YotaScale venture capital transaction
Next: 11/9/2018: Opternative venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary